Literature DB >> 17509876

Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers.

Jiro Fujimoto1, Syed Mahfuzul Alam, Israt Jahan, Eriko Sato, Hideki Sakaguchi, Teruhiko Tamaya.   

Abstract

The expression of estrogen receptor (ER)alpha and ERbeta mRNAs did not show any specific manner according to clinical backgrounds in ovarian cancers. On the other hand, the levels of estrogen-related receptor (ERR)alpha mRNA increased with clinical stages regardless of histopathological types in ovarian cancers. However, ERRbeta and ERRgamma mRNA levels were extremely low to determine reliably. ERRalpha can bind to the steroid receptor coactivator family without any ligands, and drive transcription activity of the target genes. The manner of ERR and ER gene expressions might show an independent usage of common cofactors. It is speculated that the up regulation of ERRalpha might be related to advancement of ovarian cancers regardless of plausible interaction via cofactors regulated by ERs. Although ERRalpha is not directly related to growth of ovarian cancer, ERRalpha is a candidate for prognostic factors for ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509876     DOI: 10.1016/j.jsbmb.2007.03.016

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  20 in total

1.  WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration.

Authors:  Mary A Dwyer; James D Joseph; Hilary E Wade; Matthew L Eaton; Rebecca S Kunder; Dmitri Kazmin; Ching-yi Chang; Donald P McDonnell
Journal:  Cancer Res       Date:  2010-09-24       Impact factor: 12.701

2.  ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer.

Authors:  Sunghee Park; Ching-Yi Chang; Rachid Safi; Xiaojing Liu; Robert Baldi; Jeff S Jasper; Grace R Anderson; Tingyu Liu; Jeffrey C Rathmell; Mark W Dewhirst; Kris C Wood; Jason W Locasale; Donald P McDonnell
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

3.  Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells.

Authors:  Sophia Sn Lam; Abby Sc Mak; Judy Wp Yam; Annie Ny Cheung; Hextan Ys Ngan; Alice St Wong
Journal:  Mol Ther       Date:  2014-01-14       Impact factor: 11.454

4.  Molecular pathways: the metabolic regulator estrogen-related receptor α as a therapeutic target in cancer.

Authors:  Ching-yi Chang; Donald P McDonnell
Journal:  Clin Cancer Res       Date:  2012-09-27       Impact factor: 12.531

5.  A novel steroidal inhibitor of estrogen-related receptor alpha (ERR alpha).

Authors:  Sarah J Duellman; Joy M Calaoagan; Barbara G Sato; Richard Fine; Boris Klebansky; Wan-Ru Chao; Peter Hobbs; Nathan Collins; Lidia Sambucetti; Keith R Laderoute
Journal:  Biochem Pharmacol       Date:  2010-05-31       Impact factor: 5.858

6.  High expression of estrogen-related receptor α is significantly associated with poor prognosis in patients with colorectal cancer.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

7.  Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells.

Authors:  Jian-Wei Huang; Bao-Zhang Guan; Liang-Hong Yin; Fan-Na Liu; Bo Hu; Qi-Yi Zheng; Fo-Lan Li; Ying-Xue Zhong; Yu Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

8.  Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer.

Authors:  Rebecca A Stein; Ching-Yi Chang; Dmitri A Kazmin; James Way; Thies Schroeder; Melanie Wergin; Mark W Dewhirst; Donald P McDonnell
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  Gonadotropin and steroid receptors as prognostic factors in advanced ovarian cancer: a retrospective study.

Authors:  Lorenzo Alonso; Elena Gallego; Francisco Jesús González; Alfonso Sánchez-Muñoz; Esperanza Torres; Bella Isabel Pajares; Stephanie Leeflang; Camelia Baha
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

10.  ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.

Authors:  Subrata Manna; Josefine Bostner; Yang Sun; Lance D Miller; Anya Alayev; Naomi S Schwartz; Elin Lager; Tommy Fornander; Bo Nordenskjöld; Jane J Yu; Olle Stål; Marina K Holz
Journal:  Clin Cancer Res       Date:  2015-11-05       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.